AlphaCore Capital’s MacroGenics MGNX Stock Holding History

AlphaCore Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$174K	Hold	37,750	–	–	﹤0.01%	1134
2026 Q1	$109K	Sell	37,750 -323	-0.8%	-$689	﹤0.01%	914
2025 Q4	$61.3K	Buy	+38,073	New	+$59.9K	﹤0.01%	1143

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AlphaCore Capital's MGNX Position: Q2 2026 in Review

AlphaCore Capital held its MacroGenics (MGNX) position steady in Q2 2026 at 37,750 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #1134.

AlphaCore Capital first reported a position in MGNX in Q4 2025 and has held it in 3 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

AlphaCore Capital held 37,750 shares of MacroGenics worth $174K as of Q2 2026.
AlphaCore Capital left its MacroGenics share count unchanged in Q2 2026.
MacroGenics made up ﹤0.01% of AlphaCore Capital's portfolio in Q2 2026, its #1134 holding.
AlphaCore Capital first reported a position in MacroGenics in Q4 2025 and has held it in 3 quarters since.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.